Cutler Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,917
Closed -$83.3K 4121
2022
Q4
$79K Sell
2,917
-11,522
-80% -$527K 0.01% 1306
2022
Q3
$777K Buy
14,439
+6,750
+88% +$347K 0.05% 379
2022
Q2
$310K Buy
7,689
+2,165
+39% +$107K 0.02% 748
2022
Q1
$365K Buy
5,524
+3,264
+144% +$223K 0.02% 818
2021
Q4
$226K Buy
+2,260
New +$234K 0.01% 1226
2021
Q3
Sell
-21
Closed -$2.5K 5928
2021
Q2
$2K Buy
+21
New +$2.83K ﹤0.01% 4991
2020
Q1
Sell
-3,200
Closed -$246K 4230
2019
Q4
$250K Sell
3,200
-2,228
-41% -$161K 0.02% 719
2019
Q3
$346K Buy
+5,428
New +$478K 0.03% 476

Other funds holding GH

Cutler Group's GH Position: Q1 2023 in Review

Cutler Group sold out of Guardant Health (GH) in Q1 2023, closing a stake of 2,917 shares — an estimated $83.3K sold.

Cutler Group first reported a position in GH in Q3 2019 and held it in 8 quarters. The position peaked at $777K in Q3 2022. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • Cutler Group reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 2,917 Guardant Health shares in Q1 2023, an estimated $83.3K.
  • Cutler Group first reported a position in Guardant Health in Q3 2019 and held it in 8 quarters.
  • Cutler Group's Guardant Health position peaked at $777K in Q3 2022.
  • 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.